Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China · Delayed Price · Currency is CNY 28.69
+0.34 (1.20%)
May 20, 2026, 11:05 AM CST
SHA:600566 Market Cap
SHA:600566 has a market cap or net worth of 26.13 billion as of May 19, 2026. Its market cap has increased by 7.59% in one year.
Market Cap
26.13B
Enterprise Value
14.64B
Revenue
5.90B
Ranking
n/a
PE Ratio
15.00
Stock Price
28.69
Market Cap Chart
Since December 24, 2013, SHA:600566's market cap has increased from 2.74B to 26.13B, an increase of 854.40%. That is a compound annual growth rate of 19.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 26.13B | 7.85% |
| Dec 31, 2025 | 24.23B | -9.61% |
| Dec 31, 2024 | 26.80B | -7.49% |
| Dec 29, 2023 | 28.97B | 15.46% |
| Dec 30, 2022 | 25.09B | -0.32% |
| Dec 31, 2021 | 25.17B | 40.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humanwell Healthcare (Group) | 29.71B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 28.79B |
| Shijiazhuang Yiling Pharmaceutical | 27.62B |
| Livzon Pharmaceutical Group | 25.21B |
| Dizal (Jiangsu) Pharmaceutical | 24.80B |
| Zhejiang Huahai Pharmaceutical | 24.62B |
| Walvax Biotechnology | 22.89B |
| Kangmei Pharmaceutical | 22.40B |